Literature DB >> 12972360

Radiotherapy-induced ear toxicity.

Barbara A Jereczek-Fossa1, Andrzej Zarowski, Franco Milani, Roberto Orecchia.   

Abstract

Despite their particular functional consequences, radiotherapy-induced ear injuries remain under-evaluated and under-reported. These reactions may have acute or late character, may affect all structures of the hearing organ, and result in conductive, sensorineural or mixed hearing loss. Up to 40% of patients have acute middle ear side effects during radical irradiation including acoustic structures and about one-third of patients develop late sensorineural hearing loss (SNHL). Total radiotherapy dose and tumour site seem to be among the most important factors associated with the risk of hearing impairment. Thus, reduction in radiation dose to the auditory structures should be attempted whenever possible. New radiotherapy techniques (3-dimensional conformal irradiation, intensity modulated radiotherapy, proton therapy) allow better dose distribution with lower dose to the non-target organs. Treatment of acute and late external otitis is mainly conservative and includes the anti-inflammatory agents (applied topically and systematically). Post-radiation chronic otitis media and the eustachian tube pathology may be managed with tympanic membrane incision with insertion of a tympanostomy tube (grommet), although the benefit of such approach is controversial and some authors advocate a more conservative approach. In these patients the functional deficit can be alleviated by application of bone conduction hearing aids such as, e.g., the bone anchored hearing aid (BAHA). There is no standard therapy for post-irradiation sudden or progressive SNHL yet corticosteroid therapy, rheologic medications, hyperbaric oxygen or carbogen therapy are usually employed (as for idiopathic SNHL), although controversial data on the efficacy of these treatment modalities have been published. In selected cases with bilateral profound hearing loss or total deafness, cochlear implants may prove effective. Further improvements in radiotherapy techniques and progress in otologic diagnostics and therapy may allow better prevention and management of radiation-related acoustic injury.

Entities:  

Mesh:

Year:  2003        PMID: 12972360     DOI: 10.1016/s0305-7372(03)00066-5

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  49 in total

Review 1.  Radiation therapy and hearing loss.

Authors:  Niranjan Bhandare; Andrew Jackson; Avraham Eisbruch; Charlie C Pan; John C Flickinger; Patrick Antonelli; William M Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 2.  Radiotherapy and wound healing.

Authors:  Emma-Louise Dormand; Paul E Banwell; Timothy E E Goodacre
Journal:  Int Wound J       Date:  2005-06       Impact factor: 3.315

3.  Temporal Bone Paraganglioma: Hearing Outcomes and Rehabilitation.

Authors:  David D Walker; Seilesh Babu
Journal:  J Neurol Surg B Skull Base       Date:  2019-02-14

4.  Hearing Preservation in Stereotactic Radiosurgery for Vestibular Schwannoma.

Authors:  Anthony M Tolisano; Jacob B Hunter
Journal:  J Neurol Surg B Skull Base       Date:  2019-01-10

5.  Ionizing Radiation Blocks Hair Cell Regeneration in Zebrafish Lateral Line Neuromasts by Preventing Wnt Signaling.

Authors:  Rong Li; Guixiang Liao; Guo Yin; Baiyao Wang; Miaohong Yan; Xiaoshan Lin; Wenqing Zhang; Xiaohui Chen; Shasha Du; Yawei Yuan
Journal:  Mol Neurobiol       Date:  2017-02-13       Impact factor: 5.590

6.  BAHA: Bone-Anchored Hearing Aid.

Authors:  Abdulrahman Hagr
Journal:  Int J Health Sci (Qassim)       Date:  2007-07

7.  Measuring uncertainty in dose delivered to the cochlea due to setup error during external beam treatment of patients with cancer of the head and neck.

Authors:  M Yan; D Lovelock; M Hunt; J Mechalakos; Y Hu; H Pham; A Jackson
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

8.  Intraoperative radiation therapy as adjuvant treatment in locally advanced stage tumours involving the middle ear: a hypothesis-generating retrospective study.

Authors:  G Cristalli; G Mercante; L Marucci; A Soriani; S Telera; G Spriano
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-04-29       Impact factor: 2.124

9.  Glutathione S-transferase P1 single nucleotide polymorphism predicts permanent ototoxicity in children with medulloblastoma.

Authors:  Surya Rednam; Michael E Scheurer; Adekunle Adesina; Ching C Lau; Mehmet Fatih Okcu
Journal:  Pediatr Blood Cancer       Date:  2012-10-12       Impact factor: 3.167

10.  Contribution of bone marrow hematopoietic stem cells to adult mouse inner ear: mesenchymal cells and fibrocytes.

Authors:  Hainan Lang; Yasuhiro Ebihara; Richard A Schmiedt; Hitoshi Minamiguchi; Daohong Zhou; Nancy Smythe; Liya Liu; Makio Ogawa; Bradley A Schulte
Journal:  J Comp Neurol       Date:  2006-05-10       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.